Manipal Health Enterprises charts AI‑enabled expansion and adds 2,426 beds by 2030

Expansion strategy across new geographies Manipal Health Enterprises Ltd (MHE) disclosed in its FY 2026 annual report that it is actively scouting strategic opportunities in Telangana, Kerala, Andhra Pradesh, Chhattisgarh and the Delhi‑NCR region. The aim is to deepen its footprint in markets where the group already has a presence, selecting locations that complement its existing network. Parallel to this, Manipal Hospitals – the clinical arm of the group – is evaluating inorganic growth in Karnataka, Maharashtra and Goa (including the high‑growth Mumbai‑Pune corridor) and in Eastern India covering West Bengal, Odisha, Jharkhand and Sikkim. Recent acquisitions such as Sahyadri Hospitals in Maharashtra and Medica Synergie in the east illustrate the pace of consolidation. ## Juhu greenfield project – a flagship investment A cornerstone of the expansion plan is the greenfield hospital in Juhu, Mumbai. The group completed the acquisition of the remaining land and building for a total consideration of **Rs 495 crore**, of which **Rs 130 crore** is contingent on the fulfilment of specific conditions. The project is expected to bolster Manipal’s presence in the lucrative Mumbai‑Pune economic corridor. ## AI‑driven ‘physical plus digital’ model Manipal is shifting toward a hybrid care model that blends physical infrastructure with digital capabilities powered by artificial intelligence. Key technology initiatives include: * **Unified Hospital Information System (HIS)** – linking clinical, diagnostic and administrative workflows across all facilities. * **AI‑enabled nursing handovers** – already live in 24 hospitals, improving shift‑change accuracy and patient safety. * **Wireless patient monitoring platforms** – providing real‑time vitals to clinicians. * **AI‑driven call‑centre automation** – chat, voice and omnichannel assistants handling triage queries and appointment bookings. These tools are intended to increase operational efficiency, reduce manual errors and enhance patient experience. ## Clinical focus and infrastructure upgrades The group’s clinical strategy, branded **“CONGO‑R,”** concentrates on six high‑complexity specialties: cardiac sciences, oncology, neurosciences, gastro‑sciences, orthopaedics and renal sciences. In FY 2025‑26 these specialties generated **64.3 % of gross inpatient revenue**. To support this focus, Manipal is investing in advanced equipment such as robotic surgical systems, linear accelerators for radiotherapy and PET‑CT scanners. ## Financial performance and capacity outlook For the fiscal year ending March 2026, Manipal Health Enterprises reported: * **Revenue from operations:** Rs 10,336 crore (up 25.4 % YoY) * **EBITDA:** Rs 2,644 crore * **Network size:** 49 hospitals, 13,037 licensed beds across 14 states/UTs, serving over **76 lakh patients**. The company added **over 5,500 beds** between FY 2020‑21 and FY 2025‑26, positioning itself as the leading consolidator among private hospital chains in India by bed additions. Looking ahead, Manipal aims to increase its licensed bed count by **approximately 2,426 beds by 2030** – split between 483 brownfield and 1,943 greenfield additions. ## Leadership outlook Managing Director and CEO Dilip Jose said, “The next phase of Manipal Hospitals' journey will be defined not only by the capacity we add, but by how effectively we harness the collective strengths of our people, clinical expertise, technology platforms and integrated network.” ## What this means for Indian healthcare Manipal’s aggressive expansion and AI integration signal a broader shift in India’s private healthcare sector toward larger, technology‑enabled networks. The focus on high‑complexity specialties aligns with rising demand for advanced treatments, while the AI initiatives aim to address staffing constraints and improve patient throughput. --- **What to watch:** * Progress on the Juhu greenfield hospital and its impact on the Mumbai‑Pune market. * Roll‑out of AI‑enabled nursing handovers and call‑centre automation across the entire network. * Potential acquisitions in the identified target states, especially in Eastern India. * Achievement of the 2,426‑bed target and its effect on Manipal’s market share. * Updates on the performance of the CONGO‑R specialties as a share of overall revenue.